Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis-Reference-Cited by-同舟云学术

Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

Published:2005-05 Issue:5 Volume:60 Page:693-696
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Oldhoff J. M.,Darsow U.,Werfel T.,Katzer K.,Wulf A.,Laifaoui J.,Hijnen D. J.,Plotz S.,Knol E. F.,Kapp A.,Bruijnzeel-Koomen C. A. F. M.,Ring J.,Bruin-Weller M. S.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2005.00791.x/fullpdf

Reference17 articles.

1. Interleukin-5, eosinophils, and disease

2. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.

3. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals

4. Development of IL-5 Receptor Antagonists

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopic dermatitis and IgE-mediated food allergy;Annals of Allergy, Asthma & Immunology;2024-09

2. IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation;Scientific Reports;2024-08-06

3. Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD);International Journal of Molecular Sciences;2024-07-11

4. Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases;Biomedicines;2024-07-10

5. Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis;Journal of Proteome Research;2024-07-10